Search Results - "Sauder, Candice"

ASO Author Reflections: Disparities Exist for Adolescent Young Adult Breast Cancer Survivors by Bellini, Alyssa, Sauder, Candice A. M.

Get full text

Shifting paradigms for the treatment of ductal carcinoma in situ: Less is more by Sauder, Candice A.M., Abidi, Hira, Bold, Richard J.

“…Ductal carcinoma in situ is a diverse disease in which only 50% of lesions progress to invasive carcinoma, but unfortunately, all patients receive similar…”
Get full text

ASO Author Reflections: Deescalating Therapy for Older Men with Early Estrogen Receptor Positive Breast Cancer by Perry, Lauren M., Bateni, Sarah B., Sauder, Candice A. M.

Get full text

Survival After Contralateral Secondary Breast Cancer by Age Group in California by Perry, Lauren M., Keegan, Theresa H. M., Li, Qian, Bold, Richard J., Antonino, Nicholas F., Maguire, Frances B., Sauder, Candice A. M.

“…Purpose Breast cancer (BC) is the most common secondary cancer and has poorer survival than primary BC (pBC) after any prior malignancy. For BC survivors,…”
Get full text

ASO Visual Abstract: Survival After Contralateral Secondary Breast Cancer by Age Group in California by Perry, Lauren M., Keegan, Theresa H. M., Li, Qian, Bold, Richard J., Antonino, Nicholas F., Maguire, Frances B., Sauder, Candice A. M.

Get full text

Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study by Abrahão, Renata, Brunson, Ann, Ruddy, Kathryn J., Li, Qian, Li, Judy, Ryder, Mabel M., Chubak, Jessica, Nichols, Hazel B., Sauder, Candice A. M., Gray, Marlaine F., Hahn, Erin E., Wun, Ted, Keegan, Theresa H. M.

“…Background Cancer survivors have increased risk of endocrine complications, but there is a lack of information on the occurrence of specific endocrinopathies…”
Get full text

ASO Author Reflections: Decreased Survival from Secondary Breast Cancer in Women of All Ages by Sauder, Candice A. M., Keegan, Theresa H. M.

Get full text

Chemotherapy After Diagnosis of Malignant Bowel Obstruction is Associated with Superior Survival for Medicare Patients with Advanced Malignancy by Bateni, Sarah B., Gingrich, Alicia A., Kirane, Amanda R., Sauder, Candice A. M., Gholami, Sepideh, Bold, Richard J., Meyers, Frederick J., Canter, Robert J.

“…Background Although malignant bowel obstruction (MBO) often is a terminal event, systemic therapies are advocated for select patients to extend survival. This…”
Get full text

Secondary Breast Cancer Sociodemographic Characteristics and Survival by Age Group by Sauder, Candice A. M., Li, Qian, Bold, Richard J., Ruddy, Kathryn J., Keegan, Theresa H. M.

“…Background Secondary cancers account for 16% of all new cancer diagnoses, with breast cancer (BC) the most common secondary cancer. We have shown that…”
Get full text

ASO Author Reflections: Surgical Treatment for Male Breast Cancer in the Modern Era by Sauder, Candice A. M.

Get full text

The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis by Bateni, Sarah B., Perry, Lauren M., Zhao, Xiao, Arora, Mili, Daly, Megan E., Stewart, Susan L., Bold, Richard J., Canter, Robert J., Sauder, Candice A. M.

“…Purpose Current treatment guidelines for male breast cancer are guided by female-only trials despite data suggesting distinct clinicopathologic differences…”
Get full text

Disparities in the Occurrence of Late Effects following Treatment among Adolescent and Young Adult Melanoma Survivors by Gingrich, Alicia A, Sauder, Candice A M, Goldfarb, Melanie, Li, Qian, Wun, Ted, Keegan, Theresa H M

“…Melanoma is the third most common cancer in the adolescent and young adult (AYA) population; however, no studies have addressed the occurrence of adverse…”
Get full text

ASO Visual Abstract: Chemotherapy After Diagnosis of Malignant Bowel Obstruction is Associated with Greater Survival for Medicare Patients with Advanced Malignancy by Bateni, Sarah B., Gingrich, Alicia A., Kirane, Amanda R., Sauder, Candice A. M., Gholami, Sepideh, Bold, Richard J., Meyers, Frederick J., Canter, Robert J.

Get full text

ASO Visual Abstract: Secondary Breast Cancer Sociodemographic Characteristics and Survival by Age Group by Sauder, Candice A. M., Li, Qian, Bold, Richard J., Ruddy, Kathryn J., Keegan, Theresa H. M.

Get full text

Is Breast-Conserving Therapy Appropriate for Male Breast Cancer Patients? A National Cancer Database Analysis by Bateni, Sarah B., Davidson, Anders J., Arora, Mili, Daly, Megan E., Stewart, Susan L., Bold, Richard J., Canter, Robert J., Sauder, Candice A. M.

“…Background Current treatment guidelines for male breast cancer are predominantly guided by female-only clinical trials. With scarce research, it is unclear…”
Get full text

Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California by Abrahão, Renata, Brunson, Ann, Chubak, Jessica, Wernli, Karen J., Nichols, Hazel B., Chao, Chun, Ruddy, Kathryn J., Hahn, Erin E., Li, Qian, Malogolowkin, Marcio H., Sauder, Candice A.M., Kushi, Lawrence H., Wun, Ted, Keegan, Theresa H.M.

“…Venous thromboembolism (VTE), a common complication in cancer patients, occurs more often during the initial phase of treatment. However, information on VTE…”
Get full text

Characteristics and Outcomes for Secondary Breast Cancer in Childhood, Adolescent, and Young Adult Cancer Survivors Treated with Radiation by Sauder, Candice A M, Li, Qian, Othieno, Alisha, Cruz, Daisy, Arora, Mili, Bold, Richard J, Meyers, Fredrick J, Keegan, Theresa H M

“…Radiotherapy is used to treat many adolescent and young adult (AYA) and childhood cancer patients and is a risk factor for secondary breast cancer. While…”
Get full text

Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review by Sauder, Candice A.M., Bateni, Sarah B., Davidson, Anders J., Nishijima, Daniel K.

“…The surgical guidelines for male breast cancer (MBC) have been largely guided by female-predominant clinical trials. Because no clinical trial has been…”
Get full text

Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial by Piltin, Mara A., Norwood, Peter, Ladores, Velle, Mukhtar, Rita A., Sauder, Candice A., Golshan, Mehra, Tchou, Julia, Rao, Roshni, Lee, Marie Catherine, Son, Jennifer, Reyna, Chantal, Hewitt, Kelly, Kuerer, Henry, Ahrendt, Gretchen, Greenwalt, Ian, Tseng, Jennifer, Postlewait, Lauren, Howard-McNatt, Marissa, Jaskowiak, Nora, Esserman, Laura J., Boughey, Judy C.

“…Background Internal mammary lymphadenopathy (IML) plays a role in breast cancer stage and prognosis. We aimed to evaluate method of IML detection, how IML…”
Get full text

ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy—Results from the I-SPY2 Clinical Trial by Piltin, Mara A., Norwood, Peter, Ladores, Velle, Mukhtar, Rita A., Sauder, Candice A., Golshan, Mehra, Tchou, Julia, Rao, Roshni, Lee, Marie Catherine, Son, Jennifer, Reyna, Chantal, Hewitt, Kelly, Kuerer, Henry, Ahrendt, Gretchen, Greenwalt, Ian, Tseng, Jennifer, Postlewait, Lauren, Howard-McNatt, Marissa, Jaskowiak, Nora, Esserman, Laura J., Boughey, Judy C.

Get full text